• Left to right: Business Director Marion Micoud, CEO of Cowan Australia Dominic Walsh, Account Manager Mayeule Graff and Senior Designer Kaushik S.
    Left to right: Business Director Marion Micoud, CEO of Cowan Australia Dominic Walsh, Account Manager Mayeule Graff and Senior Designer Kaushik S.
Close×

International design agency Cowan has expanded its Australian team and added French pharmaceutical giant Sanofi to its list of design clientele.

Cowan’s Sydney-based office has welcomed three new members to its team, including Marion Micoud, who was formerly part of global consulting and design firm, Landor, and now leads as business director in her new role.

Mayeule Graff and Kaushik S have also joined the Sydney Cowan team as account manager and senior designer, respectively.

Cowan Australia CEO Dominic Walsh said the new team and addition of Sanofi to Cowan’s accounts were both an exciting next step in growing the company’s Australian presence.

“The expansion of the team boosts our growing innovations expertise which, together with our traditional skills in retail and packaging, positions us well to help marketers make the most of the growing opportunities in our region,” he said.

““We’re also acquiring exciting new accounts such as Sanofi, working with their Consumer Healthcare division which includes brands such as Cenovis.”

Cowan relaunched in Australia in August as a result of growing client demand in the Australasian market for regional-based brand designs.

Food & Drink Business

Advanced biomanufacturer, Cauldron Ferm, has raised $13.25 million in a Series A2 priced round led by Main Sequence Ventures, with participation from Horizons Ventures, SOSV, and NGS Super.

Global consumer goods business, Unilever, has confirmed it is in discussions with McCormick & Co on the sale of its Food business. Both companies have released statements saying while negotiations are ongoing there is no certainty of a deal.

Australian organisations could gain access to the world’s largest pooled research fund by early 2027, as the federal government begins treaty negotiations on association to Horizon Europe, the European Union’s $155 billion flagship research and innovation funding program.